Combining new tools in Danish healthcare to drive value by delivering better patient outcomes


EFPIA believes that future health systems should orientate all their resources toward delivering better outcomes – thereby maximising value. As the EFPIA POWER Up report emphasises, measured outcomes should be relevant to patients themselves and should be assessed across the full cycle of care, i.e. encompassing all healthcare services and providers involved in a patient’s care.

We caught up with one of our member companies, Roche (Denmark), to learn about a value-based healthcare partnership they have been working on with the Capital Region of Denmark and Herlev Gentofte University Hospital.

The pilot project is a public-private innovative partnership (PPIP) built on value-based healthcare principles. It aims to explore novel, data-enabled and outcomes-driven approaches to improve the care of patients with non-clear cell renal carcinoma (nccRCC). nccRCC is a group of rare cancers for which there are limited treatment options and patient prognosis remains poor.1

The primary objective of the project was to sustainably improve the patient journey – powering the use of data to improve care for these patients and deliver the best outcomes for them.

A core team, which included members from all partnership organisations, worked together to design a new pathway that uses enriched molecular and patient data to guide, support and adjust treatment decisions. This included new diagnostic and monitoring tools such as genomic testing, cfDNA testing, and proactive patient-reported outcomes (PROs), as well as targeted treatment. Patients were monitored weekly at home during treatment in terms of PROs, response, and biological sensor data. These real world data measuring individual patient value feed into a Dashboard at the hospital to guide, support and adjust treatment.

As part of the partnership, the team aims to demonstrate the value of data-enabled and outcomes-oriented care in practice in order to foster further experimentation of similar approaches as well as adoption in routine care. Their hope is that pilot projects such as this will pave the way towards value-based procurement, including a holistic perspective on patient pathway optimisation versus single technology acquisition, and rewarding comprehensive patient and economic value.

The measurement and use of patient-centric outcomes data to improve value through better and faster decision making is a core priority identified in the EFPIA POWER Up Report. EFPIA believes the Danish pilot is a great example of our industry embracing the opportunity of innovation through partnerships to generate value to patients and health systems. You can read more about our POWER Up priorities for a future-proof health system here: It’s time to POWER Up health systems: a vision for future-proof health systems.



[1] Linehan WM et al. Non-clear cell renal cancer: Disease-based management and opportunities for targeted therapeutic approaches. Semin Oncol. 2013;40(4):511-520.